Literature DB >> 26405154

A highly recurrent novel missense mutation in CD28 among angioimmunoblastic T-cell lymphoma patients.

Seung Ho Lee1, Ji Sun Kim1, Jaesang Kim2, Seok Jin Kim3, Won Seog Kim3, Sanghyuk Lee2, Young Hyeh Ko4, Hae Yong Yoo5.   

Abstract

Entities:  

Keywords:  CD28; angioimmunoblastic T-cell lymphoma; somatic mutation

Mesh：

Substances：

Year:  2015        PMID： 26405154      PMCID： PMC4666342          DOI： 10.3324/haematol.2015.133074

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  14 in total

1.  A point mutation in CD28 distinguishes proliferative signals from survival signals.

Authors:  K Okkenhaug; L Wu; K M Garza; J La Rose; W Khoo; B Odermatt; T W Mak; P S Ohashi; R Rottapel
Journal:  Nat Immunol       Date:  2001-04       Impact factor: 25.606

2.  Grb2 and Gads exhibit different interactions with CD28 and play distinct roles in CD28-mediated costimulation.

Authors:  Ryosuke Watanabe; Yohsuke Harada; Kei Takeda; Jun Takahashi; Kazunobu Ohnuki; Shuhei Ogawa; Daisuke Ohgai; Nanako Kaibara; Osamu Koiwai; Kazunari Tanabe; Hiroshi Toma; Kazuo Sugamura; Ryo Abe
Journal:  J Immunol       Date:  2006-07-15       Impact factor: 5.422

3.  GRID: a novel Grb-2-related adapter protein that interacts with the activated T cell costimulatory receptor CD28.

Authors:  J H Ellis; C Ashman; M N Burden; K E Kilpatrick; M A Morse; P A Hamblin
Journal:  J Immunol       Date:  2000-06-01       Impact factor: 5.422

Review 4.  CD28/B7 system of T cell costimulation.

Authors:  D J Lenschow; T L Walunas; J A Bluestone
Journal:  Annu Rev Immunol       Date:  1996       Impact factor: 28.527

5.  The cytoplasmic domain of CD28 is both necessary and sufficient for costimulation of interleukin-2 secretion and association with phosphatidylinositol 3'-kinase.

Authors:  P H Stein; J D Fraser; A Weiss
Journal:  Mol Cell Biol       Date:  1994-05       Impact factor: 4.272

6.  Analysis of CD28 cytoplasmic tail tyrosine residues as regulators and substrates for the protein tyrosine kinases, EMT and LCK.

Authors:  P D King; A Sadra; J M Teng; L Xiao-Rong; A Han; A Selvakumar; A August; B Dupont
Journal:  J Immunol       Date:  1997-01-15       Impact factor: 5.422

7.  Binding of phosphatidylinositol-3-OH kinase to CD28 is required for T-cell signalling.

Authors:  F Pagès; M Ragueneau; R Rottapel; A Truneh; J Nunes; J Imbert; D Olive
Journal:  Nature       Date:  1994-05-26       Impact factor: 49.962

8.  International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes.

Authors:  Julie Vose; James Armitage; Dennis Weisenburger
Journal:  J Clin Oncol       Date:  2008-07-14       Impact factor: 44.544

9.  T-cell antigen CD28 interacts with the lipid kinase phosphatidylinositol 3-kinase by a cytoplasmic Tyr(P)-Met-Xaa-Met motif.

Authors:  K V Prasad; Y C Cai; M Raab; B Duckworth; L Cantley; S E Shoelson; C E Rudd
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-29       Impact factor: 11.205

10.  T cell antigen CD28 binds to the GRB-2/SOS complex, regulators of p21ras.

Authors:  H Schneider; Y C Cai; K V Prasad; S E Shoelson; C E Rudd
Journal:  Eur J Immunol       Date:  1995-04       Impact factor: 5.532
View more
  17 in total

1.  Recurrent activating mutations of CD28 in peripheral T-cell lymphomas.

Authors:  J Rohr; S Guo; J Huo; A Bouska; C Lachel; Y Li; P D Simone; W Zhang; Q Gong; C Wang; A Cannon; T Heavican; A Mottok; S Hung; A Rosenwald; R Gascoyne; K Fu; T C Greiner; D D Weisenburger; J M Vose; L M Staudt; W Xiao; G E O Borgstahl; S Davis; C Steidl; T McKeithan; J Iqbal; W C Chan
Journal:  Leukemia       Date:  2015-12-31       Impact factor: 11.528

2.  Functional analysis of acquired CD28 mutations identified in cutaneous T cell lymphoma.

Authors:  Grzegorz B Gmyrek; Jeanette Pingel; Jaehyuk Choi; Jonathan M Green
Journal:  Cell Immunol       Date:  2017-07-10       Impact factor: 4.868

3.  Genetic alterations affecting GTPases and T-cell receptor signaling in peripheral T-cell lymphomas.

Authors:  Rebecca L Boddicker; Gina L Razidlo; Andrew L Feldman
Journal:  Small GTPases       Date:  2017-01-06

Review 4.  Recent Progress in the Understanding of Angioimmunoblastic T-cell Lymphoma.

Authors:  Manabu Fujisawa; Shigeru Chiba; Mamiko Sakata-Yanagimoto
Journal:  J Clin Exp Hematop       Date:  2017

Review 5.  Clinical impact of recurrently mutated genes on lymphoma diagnostics: state-of-the-art and beyond.

Authors:  Richard Rosenquist; Andreas Rosenwald; Ming-Qing Du; Gianluca Gaidano; Patricia Groenen; Andrew Wotherspoon; Paolo Ghia; Philippe Gaulard; Elias Campo; Kostas Stamatopoulos
Journal:  Haematologica       Date:  2016-09       Impact factor: 9.941

Review 6.  The curious origins of angioimmunoblastic T-cell lymphoma.

Authors:  José R Cortés; Teresa Palomero
Journal:  Curr Opin Hematol       Date:  2016-07       Impact factor: 3.284

7.  Frequent CTLA4-CD28 gene fusion in diverse types of T-cell lymphoma.

Authors:  Hae Yong Yoo; Pora Kim; Won Seog Kim; Seung Ho Lee; Sangok Kim; So Young Kang; Hye Yoon Jang; Jong-Eun Lee; Jaesang Kim; Seok Jin Kim; Young Hyeh Ko; Sanghyuk Lee
Journal:  Haematologica       Date:  2016-01-27       Impact factor: 9.941

Review 8.  Molecular understanding of peripheral T-cell lymphomas, not otherwise specified (PTCL, NOS): A complex disease category.

Authors:  Mamiko Sakata-Yanagimoto; Kota Fukumoto; Kennosuke Karube; Shigeru Chiba
Journal:  J Clin Exp Hematop       Date:  2021-03-15

9.  Genome-Wide miRNA Expression Profiling of Molecular Subgroups of Peripheral T-cell Lymphoma.

Authors:  Waseem Lone; Alyssa Bouska; Sunandini Sharma; Catalina Amador; Mallick Saumyaranjan; Tyler A Herek; Tayla B Heavican; Jiayu Yu; Soon Thye Lim; Choon Kiat Ong; Graham W Slack; Kerry J Savage; Andreas Rosenwald; German Ott; James R Cook; Andrew L Feldman; Lisa M Rimsza; Timothy W McKeithan; Timothy C Greiner; Dennis D Weisenburger; Federica Melle; Giovanna Motta; Stefano Pileri; Julie M Vose; Wing C Chan; Javeed Iqbal
Journal:  Clin Cancer Res       Date:  2021-08-23       Impact factor: 13.801

10.  Inappropriate costimulation and aberrant DNA methylation as therapeutic targets in angioimmunoblastic T-cell lymphoma.

Authors:  Mathijs Willemsen; Harry C Schouten
Journal:  Biomark Res       Date:  2017-02-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.